Enhanced CAR T-cell homing boosts treatment efficacy for osteosarcoma Post author: Post published:August 5, 2024 Post category:uncategorized Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells. You Might Also Like Cherries and berries: Nature’s sweet remedy for a healthy heart May 23, 2024 1918 flu’s true victims were not the fittest, but the most stressed October 9, 2023 Paleolithic diets are not without risks July 17, 2024